Stockscreener 앱 받기
0.3297
3.48%
0.0111
시간 외 거래:
.34
0.0103
+3.12%
전일 마감가:
$0.3186
열려 있는:
$0.30995
하루 거래량:
70,818
Relative Volume:
1.21
시가총액:
$6.23M
수익:
$389.00K
순이익/손실:
$-13.13M
주가수익비율:
-0.3194
EPS:
-1.0323
순현금흐름:
$-11.90M
1주 성능:
-2.69%
1개월 성능:
-9.67%
6개월 성능:
-54.20%
1년 성능:
-87.37%
1일 변동 폭
$0.3001
$0.3394
1주일 범위
$0.29
$0.3475
52주 변동 폭
$0.2699
$3.18
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Compare CLGN vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
0.3297 | 6.04M | 389.00K | -13.13M | -11.90M | -1.0323 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-02-17 | 개시 | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd 주식(CLGN)의 최신 뉴스
CollPlant Biotechnologies Bolsters Authorized Share Capital and Validates Resale Shares After July Private Placement - TipRanks
CollPlant Biotechnologies (CLGN) lifts share capital, files new resale opinion - Stock Titan
Loewenbaum group holds 33% CollPlant (CLGN) stake after warrant deal - Stock Titan
CollPlant Shareholders Approve Proposal at Extraordinary General Meeting - The Globe and Mail
CollPlant Biotechnologies (CLGN) investors approve EGM proposal - Stock Titan
CollPlant Biotechnologies (NASDAQ: CLGN) reverse split to boost share price - Stock Titan
CollPlant Biotechnologies (CLGN) holders buy 1,764,706 shares plus new warrants - Stock Titan
Collplant Biotechnologies Ltd (CLGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Collplant Biotechnologies Ltd - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.305|Chg%:-0.010 - TradingKey
Collplant Biotechnologies Ltd (CLGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Collplant Biotechnologies Ltd (CLGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.327|Chg%:+0.012 - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.312|Chg%:+0.040 - TradingKey
Collplant Biotechnologies Ltd (CLGN) Cash Flow - TradingKey
TradingKey - TradingKey
Collplant Biotechnologies Ltd (CLGN) Balance Sheet - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.339|Chg%:+0.019 - TradingKey
CollPlant Biotechnologies Ltd. Revenue Breakdown – NASDAQ:CLGN - TradingView
Collplant Biotechnologies Ltd (CLGN) Institutional Confidence - TradingKey
CollPlant Biotechnologies Market Sentiment - Benzinga
CollPlant Biotechnologies (CLGN) completes $10.4M exempt private securities deal - Stock Titan
CollPlant Biotechnologies (CLGN) files to resell 31M shares from 2026 PIPE - Stock Titan
CollPlant Biotechnologies Ltd SEC Filing (Jul 17, 2026) - Stock Titan
Collplant Biotechnologies Ltd (CLGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CollPlant Biotechnologies files prospectus for 31.047M share offering - scanx.trade
CollPlant Biotechnologies Files Prospectus for Resale of 31 Million Shares - Moomoo
CLGN: Selling Stockholders Plan to Offer 31.05 Million Shares - GuruFocus
CollPlant (CLGN) files F-3 to register 31.05M shares from June 2026 PIPE - Stock Titan
CollPlant Biotechnologies Calls July 29 Extraordinary Meeting to Approve Major Share Capital Increase - The Globe and Mail
CollPlant (NASDAQ: CLGN) targets 500M authorized shares in shareholder vote - Stock Titan
CollPlant Biotechnologies (CLGN) Q4 2025 Earnings: Wider‑Than‑Expected Loss Highlights Pre‑Revenue Challenges - dars.gov.et
CollPlant (Nasdaq: CLGN) raises $2.6M in share and warrant private deal - Stock Titan
CollPlant (CLGN) Secures $2.6 Million in Private Placement Offer - GuruFocus
CollPlant announces $2.6 million private placement By Investing.com - Investing.com Australia
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT - PR Newswire
CollPlant Biotechnologies Ltd. announced that it expects to receive $2.6 million in funding - marketscreener.com
CollPlant Biotechnologies (CLGN) Q4 2025 earnings summary - Quartr
Enterprise value to revenue forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Price to earnings forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Enterprise value to revenue forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView
Enterprise value to EBIT forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Price to book forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Price to book forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView
Enterprise value to EBITDA forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView
Collplant Biotechnologies Ltd (CLGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CollPlant Biotechnologies Ltd Actuals & Estimates (NASDAQ:CLGN) - TradingView
CollPlant Biotechnologies (CLGN) Faces Pressure Near Key SupportKAMA Signal - dars.gov.et
CLGN Technical Analysis & Stock Price Forecast - Intellectia AI
CollPlant Biotechnologies Clings to $0.34 in Low-Volatility ConsolidationRVOL Spike - DonanımHaber
Collplant Biotechnologies Ltd (CLGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Collplant Biotechnologies Ltd (CLGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):